These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Mevastatin, an inhibitor of HMG-CoA reductase, induces apoptosis, differentiation and Rap1 expression in HL-60 cells. Kanno T; Kobuchi H; Kajitani N; Utsumi T; Yano H; Horton AA; Yasuda T; Utsumi K Physiol Chem Phys Med NMR; 2002; 34(1):1-15. PubMed ID: 12403272 [TBL] [Abstract][Full Text] [Related]
5. Effects of simvastatin on the metabolism of polyunsaturated fatty acids and on glycerolipid, cholesterol, and de novo lipid synthesis in THP-1 cells. Risé P; Colombo C; Galli C J Lipid Res; 1997 Jul; 38(7):1299-307. PubMed ID: 9254057 [TBL] [Abstract][Full Text] [Related]
6. Modulation of COX-2 expression by statins in human monocytic cells. Habib A; Shamseddeen I; Nasrallah MS; Antoun TA; Nemer G; Bertoglio J; Badreddine R; Badr KF FASEB J; 2007 Jun; 21(8):1665-74. PubMed ID: 17317725 [TBL] [Abstract][Full Text] [Related]
7. Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. Fisher JE; Rogers MJ; Halasy JM; Luckman SP; Hughes DE; Masarachia PJ; Wesolowski G; Russell RG; Rodan GA; Reszka AA Proc Natl Acad Sci U S A; 1999 Jan; 96(1):133-8. PubMed ID: 9874784 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of geranylgeranylation mediates the effects of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors on microglia. Bi X; Baudry M; Liu J; Yao Y; Fu L; Brucher F; Lynch G J Biol Chem; 2004 Nov; 279(46):48238-45. PubMed ID: 15364922 [TBL] [Abstract][Full Text] [Related]
10. Cholesterol-modulating agents kill acute myeloid leukemia cells and sensitize them to therapeutics by blocking adaptive cholesterol responses. Li HY; Appelbaum FR; Willman CL; Zager RA; Banker DE Blood; 2003 May; 101(9):3628-34. PubMed ID: 12506040 [TBL] [Abstract][Full Text] [Related]
11. Efficiency of hepatocyte pretreatment with coenzyme Q10 against statin toxicity. Eghbal MA; Abdoli N; Azarmi Y Arh Hig Rada Toksikol; 2014 Mar; 65(1):101-8. PubMed ID: 24535294 [TBL] [Abstract][Full Text] [Related]
12. In vivo evaluation of combination therapy targeting the isoprenoid biosynthetic pathway. Haney SL; Varney ML; Chhonker Y; Talmon G; Smith LM; Murry DJ; Holstein SA Pharmacol Res; 2021 May; 167():105528. PubMed ID: 33667685 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of protein geranylgeranylation and RhoA/RhoA kinase pathway induces apoptosis in human endothelial cells. Li X; Liu L; Tupper JC; Bannerman DD; Winn RK; Sebti SM; Hamilton AD; Harlan JM J Biol Chem; 2002 May; 277(18):15309-16. PubMed ID: 11839765 [TBL] [Abstract][Full Text] [Related]
14. Mevastatin suppresses lipopolysaccharide-induced Rac activation in the human monocyte cell line THP-1. Patel TR; Corbett SA Surgery; 2003 Aug; 134(2):306-11. PubMed ID: 12947334 [TBL] [Abstract][Full Text] [Related]
15. Inhibiting geranylgeranylation increases neurite branching and differentially activates cofilin in cell bodies and growth cones. Samuel F; Reddy J; Kaimal R; Segovia V; Mo H; Hynds DL Mol Neurobiol; 2014 Aug; 50(1):49-59. PubMed ID: 24515839 [TBL] [Abstract][Full Text] [Related]
16. Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl-CoA reductase inhibition: a role for RhoA in ABCA1-mediated cholesterol efflux. Argmann CA; Edwards JY; Sawyez CG; O'Neil CH; Hegele RA; Pickering JG; Huff MW J Biol Chem; 2005 Jun; 280(23):22212-21. PubMed ID: 15817453 [TBL] [Abstract][Full Text] [Related]
17. Down-regulation of RhoA is involved in the cytotoxic action of lipophilic statins in HepG2 cells. Maeda A; Yano T; Itoh Y; Kakumori M; Kubota T; Egashira N; Oishi R Atherosclerosis; 2010 Jan; 208(1):112-8. PubMed ID: 19683239 [TBL] [Abstract][Full Text] [Related]
18. Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase. Corsini A; Mazzotti M; Raiteri M; Soma MR; Gabbiani G; Fumagalli R; Paoletti R Atherosclerosis; 1993 Jun; 101(1):117-25. PubMed ID: 8216498 [TBL] [Abstract][Full Text] [Related]
19. Modulation of COX-2 expression by statins in human aortic smooth muscle cells. Involvement of geranylgeranylated proteins. Degraeve F; Bolla M; Blaie S; Créminon C; Quéré I; Boquet P; Lévy-Toledano S; Bertoglio J; Habib A J Biol Chem; 2001 Dec; 276(50):46849-55. PubMed ID: 11591701 [TBL] [Abstract][Full Text] [Related]
20. HMG CoA reductase inhibitor-induced myotoxicity: pravastatin and lovastatin inhibit the geranylgeranylation of low-molecular-weight proteins in neonatal rat muscle cell culture. Flint OP; Masters BA; Gregg RE; Durham SK Toxicol Appl Pharmacol; 1997 Jul; 145(1):99-110. PubMed ID: 9221829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]